Literature DB >> 30195626

Ultrastructural changes in peripheral blood leukocytes in α-synuclein knockout mice.

Hammad Tashkandi1, Afshin Shameli1, Clifford V Harding1, Robert W Maitta2.   

Abstract

Effects of α-synuclein deficiency on cellular blood components have not been extensively investigated. This study evaluated ultrastructural changes of leukocytes in α-synuclein knockout (KO) mice using electron microscopy (EM). The following ultrastructural characteristics were quantified in leukocytes: mitochondria, primary granules, specific granules (SG), Golgi apparatus (GA), inclusions, rough-endoplasmic reticulum (RER), smooth-endoplasmic reticulum (SER), and cellular projections (CP). EM showed increased numbers or amounts of SG, inclusions, and SER in KO group (5.3 ± 4.5 in WT vs. 14.1 ± 10.3 in KO, p = 0.02; 0.4 ± 0.9 in WT vs. 3.2 ± 2.8 in KO, p = 0.007; and 7.7 ± 6.7 in WT vs. 17.7 ± 12.2 in KO, p = 0.03, respectively). Although CP number was not significantly different between the two groups (13.4 ± 5.3 in WT vs. 16.3 ± 7.5 in KO, p = 0.32), their size and shapes were altered in KO mice. Notably, findings occurred in the setting of significant lymphopenia. α-Synuclein deficiency leads to changes in size and shape of secretory particles and increases in SER, SG, and inclusions, indicating a potential role for α-synuclein in vesicular trafficking in leukocytes. Further studies are needed to elucidate functions mediated by α-synuclein.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Leukocytes; Morphology; Ultrastructure; α-Synuclein

Mesh:

Substances:

Year:  2018        PMID: 30195626      PMCID: PMC6163077          DOI: 10.1016/j.bcmd.2018.09.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  28 in total

1.  SNARE protein expression and localization in human cytotoxic T lymphocytes.

Authors:  Varsha Pattu; Bin Qu; Eva C Schwarz; Bettina Strauss; Lisa Weins; Shruthi S Bhat; Mahantappa Halimani; Misty Marshall; Jens Rettig; Markus Hoth
Journal:  Eur J Immunol       Date:  2012-01-05       Impact factor: 5.532

2.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

3.  A critical role for alpha-synuclein in development and function of T lymphocytes.

Authors:  Afshin Shameli; Wenbin Xiao; Yan Zheng; Susan Shyu; John Sumodi; Howard J Meyerson; Clifford V Harding; Robert W Maitta
Journal:  Immunobiology       Date:  2015-10-20       Impact factor: 3.144

4.  Identification of soluble N-ethylmaleimide-sensitive factor attachment protein receptor exocytotic machinery in human plasma cells: SNAP-23 is essential for antibody secretion.

Authors:  Elena Reales; Francisco Mora-López; Verónica Rivas; Antonio García-Poley; José A Brieva; Antonio Campos-Caro
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 5.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

Review 6.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

7.  Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.

Authors:  Shounak Baksi; Ajai K Tripathi; Neena Singh
Journal:  Free Radic Biol Med       Date:  2016-06-23       Impact factor: 7.376

8.  The localization of α-synuclein in the process of differentiation of human erythroid cells.

Authors:  Katsuya Araki; Kotomi Sugawara; Eri H Hayakawa; Kumi Ubukawa; Isuzu Kobayashi; Hideki Wakui; Naoto Takahashi; Kenichi Sawada; Hideki Mochizuki; Wataru Nunomura
Journal:  Int J Hematol       Date:  2018-04-24       Impact factor: 2.490

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  Steady increment of immature platelet fraction is suppressed by irradiation in single-donor platelet components during storage.

Authors:  Hong Hong; Wenbin Xiao; Robert W Maitta
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

View more
  6 in total

1.  Initial assessment of α-synuclein structure in platelets.

Authors:  Catherine M Stefaniuk; June Schlegelmilch; Howard J Meyerson; Clifford V Harding; Robert W Maitta
Journal:  J Thromb Thrombolysis       Date:  2021-11-19       Impact factor: 5.221

Review 2.  Alpha synuclein in hematopoiesis and immunity.

Authors:  Yu Pei; Robert W Maitta
Journal:  Heliyon       Date:  2019-10-18

Review 3.  Intracellular Alpha-Synuclein and Immune Cell Function.

Authors:  Veselin Grozdanov; Karin M Danzer
Journal:  Front Cell Dev Biol       Date:  2020-10-15

Review 4.  Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.

Authors:  Lorenzo Barba; Federico Paolini Paoletti; Giovanni Bellomo; Lorenzo Gaetani; Steffen Halbgebauer; Patrick Oeckl; Markus Otto; Lucilla Parnetti
Journal:  Mov Disord       Date:  2022-02-05       Impact factor: 9.698

5.  Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease.

Authors:  Kimberly C Paul; Alexandra M Binder; Steve Horvath; Cynthia Kusters; Qi Yan; Irish Del Rosario; Yu Yu; Jeff Bronstein; Beate Ritz
Journal:  BMC Genomics       Date:  2021-09-26       Impact factor: 3.969

Review 6.  Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies.

Authors:  Ivette M Sandoval; David J Marmion; Kimberly T Meyers; Fredric P Manfredsson
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.